Taking together, these results indicate that iadademstant inhibited CSC-driven mammosphere formation efficiency through suppressing LSD1/SOX2 axis in a luminal-B breast carcinoma, whereas the size of mammospheres in a luminal-A tumor was regulated through other underlying proliferative mechanism via LSD1. The gene discussed is KDM1A; the disease is breast carcinoma.